Business
Chimeric receives $2.5 M advance on FY25 R&D tax incentive
Chimeric receives $2.5 M advance on FY25 R&D tax incentive
About this update from Chimeric Therapeutics Limited
[{"type":"text","content":"Chimeric Therapeutics Ltd has released a press release. View Attachment","length":260,"tagName":"div"}]